Literature DB >> 2193933

Tissue reaction to subcutaneous implantation of a collagen sponge. A histological, ultrastructural, and immunological study.

K Anselme1, C Bacques, G Charriere, D J Hartmann, D Herbage, R Garrone.   

Abstract

The biocompatibility of a subcutaneously implanted bovine collagen sponge (Haemostagen) was studied in rats by analyzing tissue reactions up to 3 months by histological and ultrastructural methods; in addition, the level of serum antibodies to bovine type I collagen (the major implant collagen) was measured by solid-phase radioimmunoassay. By 8 h after implantation, the implant was completely filled with polymorphonuclear cells (PMNs). After 8 days, fibroblasts had developed a granulation tissue within the sponge and the PMNs had almost disappeared. The small residue that remained after 1 month consisted of some densely packed collagen fibrils containing giant cells, which had disappeared by 3 months. No antibodies to bovine type I collagen were found in the sera of implanted rats.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2193933     DOI: 10.1002/jbm.820240605

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  11 in total

1.  Characterization of PC12 cell proliferation and differentiation-stimulated by ECM adhesion proteins and neurotrophic factors.

Authors:  Darlene G Attiah; Ross A Kopher; Tejal A Desai
Journal:  J Mater Sci Mater Med       Date:  2003-11       Impact factor: 3.896

2.  Implantation of a novel biologic and hybridized tissue engineered bioimplant in large tendon defect: an in vivo investigation.

Authors:  Ahmad Oryan; Ali Moshiri; Abdolhamid Meimandi Parizi; Nicola Maffulli
Journal:  Tissue Eng Part A       Date:  2013-10-12       Impact factor: 3.845

Review 3.  Treg cell-based therapies: challenges and perspectives.

Authors:  Caroline Raffin; Linda T Vo; Jeffrey A Bluestone
Journal:  Nat Rev Immunol       Date:  2019-12-06       Impact factor: 53.106

Review 4.  Local application of gentamicin collagen implants in the prophylaxis of surgical site infections following gastrointestinal surgery: a review of clinical experience.

Authors:  A F J de Bruin; M P Gosselink; E van der Harst; H J T Rutten
Journal:  Tech Coloproctol       Date:  2010-06-29       Impact factor: 3.781

5.  Construction of collagen II/hyaluronate/chondroitin-6-sulfate tri-copolymer scaffold for nucleus pulposus tissue engineering and preliminary analysis of its physico-chemical properties and biocompatibility.

Authors:  Chang-Qing Li; Bo Huang; Gang Luo; Chuan-Zhi Zhang; Ying Zhuang; Yue Zhou
Journal:  J Mater Sci Mater Med       Date:  2009-09-18       Impact factor: 3.896

6.  Adherence, proliferation and collagen turnover by human fibroblasts seeded into different types of collagen sponges.

Authors:  E Middelkoop; H J de Vries; L Ruuls; V Everts; C H Wildevuur; W Westerhof
Journal:  Cell Tissue Res       Date:  1995-05       Impact factor: 5.249

7.  In vivo comparison of jellyfish and bovine collagen sponges as prototype medical devices.

Authors:  Jonathan P Widdowson; Alex J Picton; Valerie Vince; Chris J Wright; Andrew Mearns-Spragg
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2017-07-25       Impact factor: 3.368

8.  Safety and Efficacy of Bupivacaine HCl Collagen-Matrix Implant (INL-001) in Open Inguinal Hernia Repair: Results from Two Randomized Controlled Trials.

Authors:  Vic Velanovich; Paul Rider; Kenneth Deck; Harold S Minkowitz; David Leiman; Nigel Jones; Gwendolyn Niebler
Journal:  Adv Ther       Date:  2018-11-22       Impact factor: 3.845

9.  Ultralow anterior resection with implantation of gentamicin-collagen sponge and no defunctioning stoma: anastomotic leakage and local cancer relapse.

Authors:  Tomasz Michalik; Rafał Matkowski; Przemyslaw Biecek; Jozef Forgacz; Bartlomiej Szynglarewicz
Journal:  Radiol Oncol       Date:  2019-03-03       Impact factor: 2.991

10.  Evaluation of the biocompatibility and stability of allogeneic tissue-engineered cartilage in humanized mice.

Authors:  Emeline Perrier-Groult; Eléonore Pérès; Marielle Pasdeloup; Louis Gazzolo; Madeleine Duc Dodon; Frédéric Mallein-Gerin
Journal:  PLoS One       Date:  2019-05-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.